Ulissi wins in Turkey to take lead, Yates best in Iran: Daily News Digest

by Shane Stokes

October 14, 2017

Ulissi wins stage 4 of the Presidential Tour of Turkey; Yates wins final stage of the Tour of Iran; Lappartient plans to ban use of corticoids from early 2019; INRNG on the Nudge Theory and Tramadol; Archbold signs for Aqua Blue Sport; Dombrowski to rethink approach after disappointing season; Williams re-signs with Orica-Scott; Twenty20 announces first new signee in Clyne; WaowDeals Pro Cycling signs Van De Ree and Rooijakkers; VeloNews bought by previous owner Felix Magowan plus partners; See.Sense enjoys more crowdfunding success for its next intelligent light; Battle Mountain set for community screenings release; Video: Two lives saved by one bicycle; Video: Bringing the family along for the ride.

INRNG on the Nudge Theory and Tramadol

by CyclingTips

In related news to a ban on corticosteroids, INRNG talks about the use of social pressures to try to prevent teams from using cortisol and Tramadol.

Here’s an excerpt:

The self-regulating MPCC is a great idea in theory and a good idea in practice. It gets mocked when teams quit but we ought to mock the teams who sign up to an agenda for the sake of appearances and bail the moment they have to hold themselves to it. But an open letter? This looks like an impotent gesture, as if saying you can’t achieve something but might as well signal your good intentions.

Which brings us to the “nudge theory” aspect. Here is a case where it’s in everyone’s interest to ban these substances but doing so is hard work and technically different. In short it’s difficult and risky to for the UCI to enforce this unilaterally. So make it voluntary but with a twist: teams applying for a World Tour or Pro Conti licence can opt out of cortisol and Tramadol testing conducted by UCI anti-doping at their will, but this decision will be made public.

Perhaps when opting out they could publish a statement why too? Similarly test results for low cortisol or the presence of Tramadol will be made public but not bring a sanction. This turns the situation from teams subscribing to the MPCC Group to one where they have to opt out of a UCI policy, it is there right but it puts the onus on them to explain.

Click through to read the full story on INRNG.